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Abstract
 Background: The interaction of the non-deletional α+-thalassaemia mutations Haemoglobin 
Constant Spring and Haemoglobin Quong Sze with the Southeast Asian double α-globin gene deletion 
results in non-deletional Haemoglobin H disease.  Accurate detection of non-deletional Haemoglobin 
H disease, which is associated with severe phenotypes, is necessary as these mutations have been 
confirmed in the Malaysian population. 
 Methods: DNA from two families with Haemoglobin H disease was extracted from EDTA-
anticoagulated whole blood and subjected to molecular analysis for α-thalassaemia.  A duplex 
polymerase chain reaction was used to detect the Southeast Asian α-globin gene deletion.  Polymerase 
chain reaction-restriction fragment length polymorphism analysis was then carried out to determine 
the presence of Haemoglobin Constant Spring and Haemoglobin Quong Sze.  A combine- amplification 
refractory mutation system protocol was optimised and implemented for the rapid and specific 
molecular characterisation of Haemoglobin Constant Spring and Haemoglobin Quong Sze in a single 
polymerase chain reaction.  
 Results and Conclusions: The combine- amplification refractory mutation system for 
Haemoglobin Constant Spring and Haemoglobin Quong Sze, together with the duplex polymerase 
chain reaction, provides accurate pre- and postnatal diagnosis of non-deletional Haemoglobin H 
disease and allows detailed genotype analyses using minimal quantities of DNA.
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Introduction
 Thalassaemia is a public health problem 
in Malaysia, with about 4.5% of Chinese and 
2.5% of Malays being carriers of α0-thalassaemia 
(Southeast Asian (SEA) α-globin gene deletion, 
--SEA/αα) (1).  The loss of two α-globin genes in cis 
(--/αα) results in mild anaemia with microcytosis 
and hypochromic red blood cells.  The loss of three 
α-globin genes causes deletional Haemoglobin 
H (HbH) disease (--/-α), whose presentation 
ranges from moderate anaemia to thalassaemia 
intermedia.  Inheritance of α0-thalassaemia with 
an α-globin structural variant results in non-
deletional HbH disease (--/αTα), a disorder with 
a more severe phenotype than deletional HbH 
disease.  Patients with non-deletional HbH disease 
are more likely to have splenomegaly and need 
blood transfusions (2,3).
 Non-deletional α+-thalassaemia mutations 
give rise to α-globin structural variants (e.g., Hb 
Constant Spring) in addition to variants with 
structurally normal α-globin chains but that are 
expressed at a decreased level.  More than 30 
α-globin structural variants have been listed in 
the human globin gene mutation database (http://
globin.cse.psu.edu). Haemoglobin Constant 
Spring (HbCS) involves a TAA→CAA base pair 
substitution in the termination codon of the α2-
globin gene (HBA2 c.427T>C).  The end product 
is an elongated α-globin chain with additional 
31 amino acid residues (4).  It was first observed 
in Constant Spring, Jamaica, in a Chinese family 
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with haemoglobin H disease (5).  HbCS is the most 
common α-globin structural variant in Malaysia 
and in other Southeast Asian countries (6,7).  In 
Malaysia, HbCS has been reported in Malay, 
Chinese and Indian populations at frequencies 
of 2.24%, 0.66% and 0.16% respectively (8,9). 
HbCS has also been observed among Aborigines 
(“Orang Asli” population) in East and West 
Malaysia (10).  Haemoglobin Quong Sze (HbQS) 
is another non-deletional α-globin gene defect.  It 
results from a gene mutation in the α2-globin gene 
whereby the amino acid leucine is substituted by 
proline (CTG→CCG, codon 125) (11,12).  HbQS 
(HBA2 c.377T>C) is a rare and highly unstable 
haemoglobin variant reported in the Chinese 
population and in Thailand (13,14).
 Both deletional (--/-α) and non-deletional 
(--/αTα) HbH disease have been observed in the 
different ethnic groups in Malaysia, particularly 
among Malays and Chinese (15).  However, non-
deletional HbH disease caused by HbQS has not 
been previously reported, as the typical α-globin 
structural variant encountered in Malaysia is 
HbCS.
 The detection of HbCS and HbQS is carried 
out using DNA amplification techniques and 
restriction enzyme digestion of amplified PCR 
products (16–19). In Malaysia, HbCS is detected 
by molecular analysis, Hb electrophoresis, high-
performance liquid chromatography (HPLC) and 
isoelectric focusing.  However, this abnormal 
α-globin, which comprised of only 1–2% of the 
total haemoglobin, is unstable and the fraction of 
slow-moving haemoglobin can be missed when 
non-molecular techniques are used.
 This study highlights the presence of two 
α-globin structural variants, HbCS and HbQS, in 
Malaysia, as well as their molecular characterisation 




 Two families (A and B), each with a child 
with HbH disease, were referred for molecular 
characterisation for α-thalassaemia at the 
University Malaya Medical Centre (UMMC). 
Patient A was four years of age when she was 
admitted with jaundice, severe anaemia and 
a 4-cm hepatomegaly.  Family B consists of a 
Chinese couple and their 10-month-old daughter 
who was referred for pallor and lethargy.  Based 
on clinical and haematological investigations, the 
accompanying diagnosis from the consultants 
involved in both cases suggested HbH disease 
with probable involvement of HbCS.  Molecular 
characterisation of α-thalassaemia was carried 
out for both families.  The haematological and Hb 
analysis data of patients A (carried out at UMMC) 
and B (carried out at Singapore General Hospital) 
are shown in Table 1.
DNA extraction
 Ethical and institutional approval to carry 
out studies on α-thalassaemia was obtained from 
the Ethics Committee of the University Malaya 
Medical Centre (UMMC) in accordance with the 
Declaration of Helsinki. Informed and signed 
consent was also obtained from the parents of both 
families. Blood (5 mL) was collected from patients 
and family members in sodium-EDTA tubes and 
DNA was extracted using proteinase K and sodium 
dodecyl sulphate. Extracted DNA was purified 
using phenol-chloroform-isoamyl alcohol and 
precipitated with 4 M sodium acetate and ethanol.
Duplex PCR for the detection of the SEA deletion 
 The presence of the SEA α-globin gene 
deletion was detected using a duplex PCR protocol 
(20) in which the SEA deletion was amplified 
as a 730-bp fragment and the normal α-globin 
gene sequence between the ψα-α2-globin genes 
was amplified as a 136-bp fragment.  DNA from 
α-thalassaemia carriers will amplify both the 730-
bp SEA deletion-specific sequence and the normal 
136-bp ψα-α2-globin gene sequence.  DNA from a 
Hb Bart’s hydrops foetalis (--/--) will specifically 
amplify only the SEA deletion-specific fragment.
PCR-RFLP analysis for HbCS and HbQS
 The polymerase chain reaction-restriction 
fragment length polymorphism technique was used 
to detect HbCS in the families’ genomes.  A 339-bp 
sequence spanning the 3’-termination codon of the 
α2-globin gene that contains the HbCS mutation 
was amplified and then subjected to restriction 
enzyme analysis using Mse I (17).  The detection of 
HbQS was carried out by amplifying the same 339-
bp sequence spanning the 3’-termination codon of 
the α2-globin gene, followed by restriction enzyme 
digestion with Msp I (19).
Combine-ARMS for the detection of Hb CS and 
Hb QS
 The C-ARMS primers for the detection of 
HbCS and HbQS were synthesised in two forms: the 
normal gene sequences and the mutant α-globin 
gene sequences, which contain one nucleotide sub-
stitution at the 3’ end and an additional one-base 
pair mismatch at the third or fourth base from the 
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QS-M (5’-CGGTGCTCACAGAAGCCAGGAACTT-
GGCCG-3’) to amplify either a 183-bp HbCS mu-
tant band and/or a 138-bp HbQS mutant band. 
The mixture was denatured at 95°C for 5 min, fol-
lowed by 30 cycles of 93°C for 1 min, 65°C for 1 
min and 72°C for 1.5 min, and a final extension at 
72°C for 3 min.  A similar C-ARMS protocol was 
carried out for the amplification of the normal 
α-globin gene sequence; in this reaction, forward 
primer CS-1 was added to 20 pmol each of reverse 
primers CS-N (5’-AGGAGGAACGGCTACCGAG-
GCTCCAGATTA-3’) and QS-N (5’ CGGTGCT-
CACAGAAGCCAGGAACTTGGCCA-3’) to amplify 
the 183-bp HbCS and 138-bp HbQS normal bands. 
Amplified DNA was visualised after electrophore-
sis in a 1.5% agarose gel and staining with ethidium 
bromide.
3’ end.  In each reaction, amplification of a 323-bp 
region between the Gγ- and ε-globin genes of the 
β-globin gene complex in chromosome 11 (prim-
er E, 5’-AGTGCTGCAAGAAGAACAACTACC-3’ 
and primer F, 5’-CTCTGCATCATGGGCAGT-
GAGCTC-3’) was included as an internal control to 
check amplification efficiency (21).
 DNA amplification was carried out in a PCR 
mixture that contained 10X buffer (750 mM Tris-
HCl, 200 mM (NH4)2SO4, 0.1% Tween 20), 0.2 
mM of each dNTP, 1 mM MgCl2, 1 U Taq DNA 
polymerase and 1 μg of DNA, in a 25-µl reaction. 
First, 50 pmol of forward primer CS-1 (5’-CCT-
GGGCCGCACTGACCCTATT-3’) was added to 20 
pmol each of reverse primers CS-M (5’-AGGAG-
GAACGGCTACCGAGGCTCCAGATTG-3’) and 
Table 1: Haematological data and haemoglobin analysis of patients A and B with non-deletional HbH 
disease
Parameters Patient A
HbH disease with HbCS
Patient B
HbH disease with HbQS
Normal range
Sex-Age Female - 4 years Female -10 months Patient A, UMMCa
Patient B, SGHb
RBC (x1012/L) 2.57 5.88 4.0–5.4
3.8–5.5
Hb (g/dL) 5.86 9.2 11.5–14.5
10.0–15.0
MCV (fL) 74 53.5 77–91
76–96
MCH (pg) 22.8 15.7 24–30
27–32
MCHC (g/dL) 31 29.3 30–35
32–36
RDW (%) 19.2 21.6 12–15
10.9–15.7
Hb electrophoresis Hb A, Hb A2 and weak, 
Hb H bands present
HbA, HbA2 and Hb H 
bands present
-
Hb A2 2.8 % 1.8 % 2.2–3.3
2.1-3.1
Hb F - 0.2 % 0.1–1.3
0.1–5.0
HbH inclusion bodies Positive (numerous) Not in report -
Blood film Severe 
anisopoikilocytosis, 
target cells and some 
polychromatic cells 
present




numerous target cells 
present
-
a University Malaya Medical Centre, UMMC; bSingapore General Hospital, SGH
Hb, haemoglobin; RBC, red blood cell count; MCV, mean cell volume; MCH, mean cell haemoglobin; MCHC, mean cell haemoglobin 
concentration; RDW, red cell distribution width; -, not available
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Results
 Figure 1 shows the gel electrophoresis results 
of the duplex PCR (upper gel) for the detection 
of α0-thalassaemia and the C-ARMS for HbCS 
and HbQS (lower gel).  In the duplex PCR (upper 
gel), the 730-bp SEA deletion-specific band was 
observed in DNA from patient A and her mother 
(lanes 3 and 4) and in DNA from patient B (lane 
7) and her father (lane 6).  DNA from all members 
of families A and B amplified the 136-bp normal 
ψα-α2-globin genes.  In C-ARMS (lower gel), the 
183-bp HbCS-specific mutant band was amplified 
in DNA from patient A (lane 3) and her father (lane 
2).  The 138-bp HbQS specific mutant band was 
amplified in DNA from patient B and her mother 
(lanes 7 and 8).  The 323-bp internal control band 
was amplified in DNA from all the family members. 
 The family pedigree with complete genotypes 
of both families is shown above the gels in Figure 
1.  The two patients referred for molecular analysis 
were confirmed to have HbH disease; patient A 
is compound heterozygous for the SEA deletion 
and HbCS (--SEA/αCSα) and patient B is compound 
heterozygous for the SEA deletion and HbQS (--
SEA/αQSα). 
 The sensitivity of the in-house-developed 
C-ARMS was evaluated with HbCS (50 patients) and 
HbQS (10 patients) control DNA.  The respective 
183-bp HbCS and 138-bp HbQS sequences were 
amplified from the control DNA.  In addition, the 
specificity of the C-ARMS technique was evaluated 
using DNA from normal individuals (n=100); non-
specific amplification was not observed.
Discussion 
 A rapid and simple molecular method for 
the detection of α-globin structural variants is 
especially useful in regions where non-deletional 
HbH disease  is present.  Accurate detection of 
non-deletional HbH disease is necessary as these 
disorders have been associated with more severe 
phenotypes, including neonatal death, compared 
to the deletional forms of HbH disease (2, 22–24). 
HbH hydrops foetalis is usually associated with 
non-deletion mutations that give rise to hyper-
unstable α-globin chains (25).  A HbH hydrops 
foetalis case due to the association of the --SEA 
deletion with the HbQS mutation has been reported 
in a Chinese woman (26).  Affected foetuses have 
severe anaemia and symptoms consistent with 
the classic presentation of Hb Bart’s hydrops 
foetalis.  HbH disease is considered a public 
health problem in California, USA, and neonatal 
screening programs for HbH and HbCS have been 
incorporated into the universal newborn screening 
program for haemoglobinopathies in that state 
(27,28).  The haematological data show a relatively 
low red blood cell count for patient A. The patient 
is undergoing regular blood transfusion at three-
weekly intervals; her pretransfusion haemoglobin 
ranges between 8–10 g/dL, whereas her post-
transfusion haemoglobin is between 12–14 g/dL. 
 HbCS has been reported in the Malaysian 
population, with the highest frequency among 
Malays, followed by the Chinese and Indian 
populations (7,29).  The presence of HbQS in 
Malaysia has not been previously documented and 
this study presents the first report of HbH disease 
associated with HbQS in Malaysia.  In HbCS, the 
mRNA of the mutant gene is unstable and the 
small quantities of abnormal α-globins in the 
peripheral blood of HbCS patients make detection 
difficult, especially in heterozygotes (30).  The 
non-deletional α-globin gene mutation in HbQS 
results in highly unstable α-globin chains (3).  The 
detection of HbCS by gel electrophoresis requires 
fresh blood samples, and the highly unstable 
α-globin chains in HbQS make this Hb variant 
undetectable by routine electrophoresis (14). 
 Accurate detection of both HbCS and HbQS 
requires molecular techniques.  In Malaysia, where 
both disorders are likely to be involved in non-
deletional HbH disease, C-ARMS offers rapid and 
simple confirmation of diagnosis.  PCR-RFLP also 
yields accurate diagnosis, but it is more expensive 
due to the higher cost of restriction enzymes in 
Southeast Asian countries.  C-ARMS utilises five 
oligonucleotide primers that can be stored at -70oC. 
The primers E and F used for amplification of the 
323-bp internal control are the same standard 
internal control primers commonly used in single 
ARMS.  Using a standard PCR kit that includes Taq 
polymerase, 10X buffer and magnesium chloride, 
C-ARMS is cost-effective. 
 ARMS has been widely used for molecular 
characterisation and prenatal diagnosis of 
β-thalassaemia worldwide.  Using ARMS, 
characterisation of β-thalassaemia was achieved 
in 98.7% of Malaysian Chinese patients (31), 
over 97% of patients in Pakistan (32), 84.2% of 
Egyptian patients (33) and 75% of patients in the 
Khuzestan provinces of Iran (34).  A disadvantage 
usually associated with ARMS is false-positive and 
false-negative amplifications.  In our laboratory, 
careful evaluation of primer concentrations and 
PCR conditions during the development of the 
ARMS method has resulted in sensitive and 
specific amplification.  False-positive results due 
to maternal contamination can be further checked 
with DNA amplification of the VNTR locus DIS80 
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Figure 1: Gel electrophoresis of the amplified SEA deletion-specific sequence and the 
normal ψα-α2-globin genes in a duplex-PCR (upper gel) and the detection of HbCS and 
HbQS using C-ARMS (lower gel). The affected daughter in family A was admitted with 
hepatomegaly of 4cm, jaundice and severe anaemia at four years of age.  The family was 
molecularly characterised with the SEA deletion and HbCS.  Patient B was referred for 
pallor and lethargy, and she was characterised with the SEA deletion and HbQS
Upper gel. Duplex-PCR for the detection of SEA deletion
Lane 1: 100 bp DNA ladder; lane 2: father of patient A, 136 bp normal ψα-α2-globin genes region band; lane 3: 
patient A, 730 bp deletion-specific band and 136 bp normal band; lane 4: mother of patient A, 730 bp deletion-
specific band and 136 bp normal band; lane 5: water control (no DNA added); lane 6: father of patient B, 730 bp 
deletion-specific band and 136 bp normal band; Lane 7: patient B, 730 bp deletion-specific band and 136 bp normal 
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(31) and haplotype construction at six polymorphic 
restriction sites along the β-globin gene cluster (35). 
The most common α-chain variant in Southeast Asia 
is HbCS, followed by the rarer HbQS in Malaysia 
and Singapore.  The frequency of HbQS in Malaysia 
has not been reported, except for the fact that it is 
reported as a rare mutation.  Hb Pakse is another 
rare α-chain variant and has been reported more 
commonly in Thailand (36). The Combine-ARMS 
for HbCS and HbQS was specifically established 
for rapid detection of the two main non-deletional 
α+-thalassaemia mutations in Malaysia.  The 
sensitivity and specificity of this technique will 
allow confirmation of these two α-globin structural 
variants and thus yield valuable updated data on 
the actual frequencies of HbCS and HbQS in the 
Malaysian population. 
 Studies on the co-inheritance of β-thalassaemia 
with HbH disease have also shown variable clinical 
heterogeneity depending on whether deletional or 
non-deletional HbH disease is involved.  Clinicians 
and genetic counsellors must take into account the 
role of HbCS and HbQS in HbH patients in whom 
α- and β-thalassaemias and Hb variants co-exist, 
particularly in Malaysia and other countries in 
Southeast Asia.
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